Riskpilot← Back to searchSign inGet full accessDanstef AB
ABBankruptOrg 5592650765Hospital activities · NACE 8610Est. 20200 employees
Revenue 2024
SEK 266K
-36% vs 2023
EBITDA margin
-11.0%
-193% vs 2023
Equity ratio
38.4%
Financial strength
Net profit 2024
SEK -30K
-296% vs 2023
| Revenue | SEK 266K | -36% |
| EBITDA | SEK -29K | -193% |
| Net profit | SEK -30K | -296% |
| Total assets | SEK 189K | -29% |
| Equity | SEK 73K | -29% |
| Employees | 0 | — |
Legal name
Danstef AB
Org number
5592650765
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
29 juli 2020
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Verksamheten ska bedriva hälsa och sjukvård. Det ska utföras estetiska injektionsbehandlingar botox, fillers, trådlyft, Platelet Rich Plasma eller blodplättrik plasma - även kallad Dracula- eller Vampyr-behandling, samt kosmetiska behandlingar (peeling, microneedling).
Address
Email
milijana035@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 256 | 370 | 417 | 266 |
| Staff expenses | — | −0 | — | — |
| EBITDA | 40 | 39 | 31 | −29 |
| Depreciation & amort. | −0 | — | −4 | −10 |
| EBIT | 40 | 39 | 27 | −39 |
| Net financials | — | 0 | 1 | 1 |
| Profit before tax | 39 | 39 | 20 | −30 |
| Tax | −8 | −8 | −5 | — |
| Net profit | 31 | 31 | 15 | −30 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 143 | 231 | 268 | 189 |
| Equity | 56 | 87 | 103 | 73 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 86 | 144 | 157 | 117 |
| Total debt | 86 | 144 | 157 | 117 |
EBITDA margin
-11.0%
This company
15.8%
Market median
-170% vs market
20212024
Equity ratio
38.4%
This company
38.2%
Market median
+1% vs market
20212024
Return on equity
-41.4%
This company
18.4%
Market median
-325% vs market
20212024
Net profit margin
-11.3%
This company
8.1%
Market median
-240% vs market
20212024
Asset turnover
1.41×
This company
1.12×
Market median
+26% vs market
20212024
Debt / equity
1.61×
This company
0.62×
Market median
-160% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Danstef AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Biljana Jovanovic | Deputy Board Member | 0 companies |
| Milijana Nyberg | Board of Directors | 0 companies |
| Biljana Jovanovic | Deputy Board Member | 0 companies |